ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,834Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 118

$304K Total Retail Price of All Prescriptions

Rank: 50 out of 118

367 Patients Receiving at Least One Drug in Part D
89% Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Vermont
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

8% of this provider’s 367 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

5% of this provider’s 367 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%. This is far more than peers.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Vermont
LISINOPRIL 379 355 89 1 2
SIMVASTATIN 346 326 83 2 1
METOPROLOL SUCCINATE 250 227 49 3 11
HYDROCHLOROTHIAZIDE 208 188 54 4 7
FUROSEMIDE 205 192 42 5 5
WARFARIN SODIUM 204 204 22 6 9
OMEPRAZOLE 178 166 43 7 4
LEVOTHYROXINE SODIUM 177 172* 40 8 3
AMLODIPINE BESYLATE 152 152 35 9 6
METFORMIN HCL 150 145* 38 10 14
METOPROLOL TARTRATE 134 129* 31 11 10
ATORVASTATIN CALCIUM 123 118* 34 12 8
CHLORTHALIDONE 117 102 23 13 70
LORAZEPAM 115 110* 29 B 14 13
LOSARTAN POTASSIUM 113 102 20 15 16
SERTRALINE HCL 109 109 18 16 19
ALLOPURINOL 104 99* 23 17 36
ATENOLOL 98 93* 23 18 12
GABAPENTIN 96 75 20 19 15
NEXIUM 90 85* 13 20 33
RANITIDINE HCL 90 78 18 20 39
POTASSIUM CHLORIDE 86 86 17 22 23
DONEPEZIL HCL 82 82 13 23 32
FLUOXETINE HCL 74 61 13 24 44
HYDROCODONE-ACETAMINOPHEN 68 46 12 S3 25 17
CARBIDOPA-LEVODOPA 66 <11 <11 26 94
GLIPIZIDE XL 65 <11 <11 27 89
NAMENDA 62 <11 <11 28 50
CITALOPRAM HBR 59 <11 <11 29 18
TRAZODONE HCL 56 51* 20 30 22
FINASTERIDE 52 52 11 31 72
GLIMEPIRIDE 50 <11 <11 32 59
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 1, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.